Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


May 04, 2015 11:20 PM ET

Company Overview of Katholieke Universiteit Leuven

Company Overview

Katholieke Unversiteit Leuven is the oldest University in Belgium, founded in 1425.

21 Blijde-Inkomststraat

Leuven,  3000

Belgium

Founded in 2002

Phone:

32 16 324611

Key Executives for Katholieke Universiteit Leuven

Director
Innovation Advisor
Innovation Advisor
Compensation as of Fiscal Year 2014.

Katholieke Universiteit Leuven Key Developments

Katholieke Universiteit Leuven Wins EUR 1.3 Million Research and Development (R&D) Contract

European Agency for Safety and Health at Work has awarded an EUR 1.3 million (USD 1.6 million) research and development (R&D) contract to Belgium's Katholieke Universiteit Leuven. The final value of the deal does not include VAT. Under the contract Katholieke Universiteit Leuven, represented by KU Leuven Research & Development and acting upon request of Research Institute for Work and Society (HIVA), will provide a range of services in respect of occupational safety and health (OSH) in the context of micro and small enterprises (SMEs) in Europe. The aims are to help inform policy development in improvement of health and safety in SMEs, provide conclusions on what constitutes good strategies and practices currently, and provide examples of good strategies and practices, including any innovative strategies and practices.

Katholieke Universiteit Leuven Signs License and Collaboration Agreement with FIT Biotech

Katholieke Universiteit Leuven entered into a worldwide license and collaboration agreement with FIT Biotech Oy for the development of novel immunotherapeutics based on FIT Biotech's proprietary Gene Transport Unit (GTU) technology for transient in vivo expression of monoclonal antibodies. KU Leuven is a Belgium research university, while FIT Biotech is a Finland-based medical biotechnology company engaged in the development and commercialization of GTU technology and GTU product applications in DNA vaccination, as well as in immuno and gene therapies. The agreement provides KU Leuven with an exclusive worldwide license to six undisclosed proprietary antibodies or marketed recombinant products.

Similar Private Companies By Industry

Company Name Region
Dili Ferme NV Europe
Accountantskantoor Conto BVBA Europe
Somatel SA Europe
Eurotruckcenter NV Europe
Ensor Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Katholieke Universiteit Leuven, please visit www.kuleuven.ac.be. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.